| The company, which has put India on its global R&D map as a very important location for its global strategies, has plans to in-license potential research products in biopharmaceuticals and vaccines in addition to conducting clinical research for new products and sourcing bulk drugs from the country. |
| The global team, headed by a senior official from the Indianapolis headquarters of the company, will be based in Hong Kong with a special task of exploring product and service outsourcing opportunities from India and China at a micro-level, said Rajiv Gulati, managing director, Eli Lilly & Company India. |
| Gulati, said at the sidelines of the launch of Lilly's breakthrough insulin therapy in Mumbai, that India has been positioned at par with developed markets by the parent company. |
| "This would result in giving priority to the country in terms of manufacturing and product outsourcing and even for new launches," he added. |
| Eli Lilly is also firming up plans with a for contract manufacturing and seeks to increase this number with time. |
Top Section
Explore Business Standard